{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:41:44Z","timestamp":1785897704609,"version":"3.56.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We present here a case of metastatic adrenocortical carcinoma with bilateral lung nodules. The patient had been treated with mitotane therapy initially and then was later referred for chemotherapy. There was progression of disease noted on the <jats:sup>18<\/jats:sup>F-FDG PET\/CT. <jats:sup>68<\/jats:sup>Ga prostate-specific membrane antigen (PSMA) PET\/CT was planned to explore the possibility of future treatment with <jats:sup>177<\/jats:sup>Lu-DKFZ-PSMA-617. It revealed peripheral increased uptake of <jats:sup>68<\/jats:sup>Ga-HBED-CC-PSMA equal to liver uptake.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002064","type":"journal-article","created":{"date-parts":[[2018,3,25]],"date-time":"2018-03-25T21:02:23Z","timestamp":1522011743000},"page":"449-451","source":"Crossref","is-referenced-by-count":12,"title":["Prostate-Specific Membrane Antigen Expression in Adrenocortical Carcinoma on 68Ga\u2013Prostate-Specific Membrane Antigen PET\/CT"],"prefix":"10.1097","volume":"43","author":[{"given":"Saurabh","family":"Arora","sequence":"first","affiliation":[{"name":"From the *Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi; and \u2020Department of Medicine, Postgraduate Institute of Medical Education and Research, Rohtak, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishikant Avinash","family":"Damle","sequence":"additional","affiliation":[{"name":"From the *Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi; and \u2020Department of Medicine, Postgraduate Institute of Medical Education and Research, Rohtak, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"From the *Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi; and \u2020Department of Medicine, Postgraduate Institute of Medical Education and Research, Rohtak, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Averilicia","family":"Passah","sequence":"additional","affiliation":[{"name":"From the *Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi; and \u2020Department of Medicine, Postgraduate Institute of Medical Education and Research, Rohtak, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Behera","sequence":"additional","affiliation":[{"name":"From the *Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi; and \u2020Department of Medicine, Postgraduate Institute of Medical Education and Research, Rohtak, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetanjali","family":"Arora","sequence":"additional","affiliation":[{"name":"From the *Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi; and \u2020Department of Medicine, Postgraduate Institute of Medical Education and Research, Rohtak, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrasekhar","family":"Bal","sequence":"additional","affiliation":[{"name":"From the *Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi; and \u2020Department of Medicine, Postgraduate Institute of Medical Education and Research, Rohtak, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhavi","family":"Tripathi","sequence":"additional","affiliation":[{"name":"From the *Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi; and \u2020Department of Medicine, Postgraduate Institute of Medical Education and Research, Rohtak, India."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20231021","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.ejca.2013.02.034","article-title":"Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993","volume":"49","year":"2013","journal-title":"Eur J Cancer"},{"key":"bib2-20231021","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10434-999-0719-7","article-title":"Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma","volume":"6","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"bib3-20231021","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/jso.23015","article-title":"Operative management for recurrent and metastatic adrenocortical carcinoma","volume":"105","year":"2012","journal-title":"J Surg Oncol"},{"key":"bib4-20231021","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2005-2639","article-title":"Clinical review: adrenocortical carcinoma: clinical update","volume":"91","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"bib5-20231021","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1210\/jc.2001-011799","article-title":"Angiogenesis in human normal and pathologic adrenal cortex","volume":"87","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"bib6-20231021","first-page":"3192","article-title":"Five different anti\u2013prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature","volume":"59","year":"1999","journal-title":"Cancer Res"},{"key":"bib7-20231021","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2967\/jnumed.115.160382","article-title":"Prospective comparison of 18F-fluoromethylcholine versus 68Ga-PSMA PET\/CT in prostate cancer patients who have rising PSA after curative treatment and are being considered for targeted therapy","volume":"56","year":"2015","journal-title":"J Nucl Med"},{"key":"bib8-20231021","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/RLU.0000000000001139","article-title":"Elevated 68Ga prostate-specific membrane antigen activity in metastatic non\u2013small cell lung cancer","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib9-20231021","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/RLU.0000000000001072","article-title":"Rectal carcinoma on 68Ga-PSMA PET\/CT","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib10-20231021","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/jc.2015-4021","article-title":"Prostate-specific membrane antigen is a potential antiangiogenic target in adrenocortical carcinoma","volume":"101","year":"2016","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201806000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T04:55:07Z","timestamp":1697864107000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201806000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002064","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}